在婴儿发作综合征中预测治疗反应,使用EEG阶段幅度合
Soudeh Mostaghimi1, Marco A Pinto-Orellana1, Nathaniel Green1
1Department of Biomedical Engineering, University of California, Irvine, California, USA.
Epilepsia open
|March 14, 2026
概括
通过调制指数 (MI) 测量的相振幅合 (PAC) 可以预测婴儿发作综合征 (IESS) 的治疗反应. 患有较高预治疗MI的婴儿,表明大脑波合较强,不太可能对标准药物反应,这表明需要替代疗法.
科学领域:
- 神经科学是一个神经科学.
- 儿科神经学 儿科神经学
- 生物标志物发现发现
背景情况:
- 由于缺乏预测性生物标志物,婴儿发作综合征 (IESS) 治疗选择具有挑战性.
- 脑电图 (EEG) 生物标志物是指导IESS治疗决策所必需的.
- 阶段振幅合 (PAC) 在IESS患者中升高,可以作为潜在的生物标志物.
研究的目的:
- 在IESS中评估PAC对治疗反应的预测价值.
- 确定PAC是否可以为IESS患者指导个性化治疗选择.
主要方法:
- 从40名IESS患者的EEG记录 (响应者n=25,不响应者n=15) 和20名健康对照者的回顾性分析.
- 使用调制指数 (MI) 和平均矢量长度 (MVL) 测量PAC,处理前后.
- 统计分析以将治疗前的PAC值与治疗结果相关联.
主要成果:
- 在大多数受试者中,MI和MVL值在治疗后下降.
- 与响应者相比,未响应者表现出明显更高的治疗前MI (p<0.05).
- 后勤回归表明,ln{\displaystyle ln{\text{MI}} 的下降与积极治疗反应的几率增加有关.
结论:
- 调制指数 (MI) 显示出作为IESS治疗反应的预测性EEG生物标志物的潜力.
- MI可以为优化IESS管理策略提供个性化的见解.
- 这种生物标志物可以帮助识别需要更积极的治疗方法的婴儿.
相关概念视频
Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Holter Monitor: 24-Hour Monitoring
Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias V: Evaluating Dysrhythmias
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...


